JFJames D. Finnigan

James D. Finnigan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


James D. Finnigan has a total of 122 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Ultrahigh-throughput screening for sialic acid-active enzymes in the microbial genetic diversity

    by John Martínez-Salvador, Sara Trujillo-Cubillo, Laura Blas-Muñoz, Melissa Conte, Wolf-Dieter Fessner, Simon Charnock, James Finnigan, Aurelio Hidalgo

    Sialic acids (Sias) and related nonulosonic acids are critical components of glycoconjugates involved in host-pathogen interactions, immune regulation, and cell signalling. Despite their biotechnological relevance, the diversity of enzymes involved in Sia biosynthesis remains largely underexplored due to limitations in culture-dependent methods and the lack of (ultra)high-throughput screening strategies. Here, we report the development of a highly sensitive droplet-based microfluidic screening platform enabling the functional discovery of sialic acid aldolases in environmental metagenomes. The method integrates a fluorescence-coupled enzymatic cascade compatible with fluorescence-activated droplet sorting (FADS), allowing the screening of >10⁶ droplets per experiment, as well as a downstream validation strategy for the selected hits. Although some limitations were identified, the system demonstrated high sensitivity and was utilised for the screening of a metagenomic library from garden soil. During this campaign, a potential new sialic acid aldolase enzyme was identified. This work establishes a generalizable framework for measuring complex, multi-step enzymatic functions at ultrahigh throughput using coupled cascades in droplets, with direct applicability to directed evolution and activity-guided functional metagenomics. Highlights: Enzymatic cascade assay reports sialic acid aldolase activity in droplets. Dual fluorescence signal enables droplet quality control and barcoding. Optimized lysis and FADS enable plasmid recovery after droplet sorting. Droplet assay enriches NanA-positive clones by over 700-fold. Soil metagenome screening retrieves aldolase-related candidates Graphical Fig. 1. Optimization of a fluorescent cascade assay for NanA detection in droplets, validation using a mock library, and application to functional metagenomic screening. N-acetylneurminic acid (Neu5Ac), N-acetylmannosamine (ManNAc), sialic acid aldolase (NanA), Lacatate dehydrogenase (LDH), Ketorreductase Fb (FbKRED), Fluorescence Activated Droplet Sorting (FADS). Figure created with BioRender.

  • Open Access

    ro-crate-rs: Development of a Lightweight RO-Crate Rust Library for Automated Synthetic Biology

    by Matt Burridge, Zhen Ou, Katherine James, Gizem Buldum, Jesmine Lim, James Finnigan, Simon Charnock, Anil Wipat

    Advances in laboratory automation and AI-driven experimental design have increased the scale and complexity of data generated in synthetic biology. Whilst biofoundries provide significant resources and infrastructure to execute these experiments, most laboratories rely on isolated automated instruments and software systems that operate as disconnected silos, producing heterogeneous data formats with little structured metadata. This fragmentation hinders data integration, reproducibility, and downstream computational workflows. A potential solution is RO-Crate, which offers a lightweight, extensible framework for packaging research data with machine-readable metadata, but existing tooling remains immature for automation-orientated, cloud-native, or high-throughput laboratory workflows. Here, we introduce ro-crate-rs , a new suite of tools centred on a performant Rust library for constructing, validating and packaging RO-Crates across diverse compute environments and automated hardware. The library enforces RO-Crate 1.1 constraints through strong typing while enabling flexible extensions, and is complemented by a Python API and CLI for interactive use and pipeline integration. We demonstrate this combined approach through a semi-automated Old Yellow Enzyme characterisation workflow, showing how RO-Crates can capture data and metadata across multiple independent instruments. Together, these tools provide a robust foundation for FAIR-compliant, automation-ready data management and enable reproducible reconstruction of experimental workflows even in non-biofoundry settings. Availability: https://github.com/intbio-ncl/ro-crate-rs

  • Open Access

    Enzymatic synthesis of key RNA therapeutic building blocks using simple phosphate donors

    by Qinglong Meng, Caecilie Benckendorff, Charlotte Morrill, Ying Zhuo, Annette Egerström, Aisling Ní Cheallaigh, Sasha R. Derrington, Richard Obexer, Mary Ortmayer, Colin W. Levy, et al.

    The rapid emergence of RNA therapeutics has highlighted the need for more efficient, scalable and sustainable methods for their manufacture. Biocatalytic approaches hold particular promise, but rely on a secure, sustainable and low-cost supply of nucleoside triphosphate (NTP) building blocks, including those containing chemical modifications. Here we report the development of a biocatalytic approach and engineered enzymes to convert widely available nucleosides into NTPs featuring pharmaceutically relevant modifications using inexpensive phosphate donors. Importantly our strategy obviates the need for ATP as a phosphate donor that complicates NTP isolation using existing methods. To showcase the utility of our approach, we employ an engineered acid phosphatase, polyphosphate kinase and acetate kinase to produce 2′- O -methoxyethyl-ATP (2′-MOE-ATP) and 2′-fluoro-ATP, key building blocks of commercial therapeutics. Finally, we show that crude NTPs from our process can be used directly in enzymatic oligonucleotide synthesis, obviating the need for costly NTP isolation or purification steps.


  • A pyridoxal radical carboligase and imine reductase photobiocatalytic cascade for stereoselective synthesis of unnatural prolines

    by Chen Zhang, Jun Zhou, Binh Khanh Mai, Zijun Qin, James Finnigan, Samantha Gittings, Peng Liu, Yang Yang

    Cooperative photobiocatalysis is a useful strategy for achieving stereoselective intermolecular radical reactions that are not known in either biology or chemistry. The diastereoselective and enantioselective synthesis of cyclic non-canonical amino acids remains challenging using established methods. Here we report a multienzyme photobiocatalytic cascade to stereoselectively prepare polysubstituted unnatural prolines. We engineered an underexploited class of pyridoxal 5′-phosphate aldolases as new-to-nature radical carboligases to catalyse the decarboxylative C–C coupling of aspartic acid, furnishing imine-containing azacyclic non-canonical amino acids. High-throughput screening of metagenomic imine reductases led to the development of diastereoselective biocatalytic reduction and dynamic kinetic asymmetric transformation of cyclic imines, providing optically pure unnatural prolines featuring an elusive 2,5-anti stereochemistry with up to three stereocentres. Beyond its synthetic utility, this study established a new mode of radical pyridoxal enzymology by leveraging open-shell enamine catalysis, opening up avenues for developing new free radical reactions.


  • Top Cited Papers

    Diversity-oriented photobiocatalytic synthesis via stereoselective three-component radical coupling

    by Chen Zhang, Jun Zhou, Pei-Pei Xie, Silvia M. Rivera, Turki M. Alturaifi, James Finnigan, Simon Charnock, Peng Liu, Yang Yang

    Enzymatic multicomponent carbon-carbon (C–C) bond–forming reactions for diversity-oriented synthesis remain rare. Using cooperative photobiocatalysis, we developed a stereoselective three-component radical-mediated C–C coupling previously unknown in both organic chemistry and biochemistry. Directed evolution of repurposed pyridoxal decarboxylases enabled full fragment variability in this three-component coupling, giving rise to six classes of valuable products, many of which were inaccessible with other methods, even in a racemic fashion. This enzymatic platform integrates a range of asymmetric catalysis principles, including remote stereocenter construction, stereodivergent catalysis, kinetic resolution, and parallel kinetic resolution, achieving excellent diastereo- and enantiocontrol over radical intermediates. The broad substrate scope and complementary specificities of evolved enzyme variants enabled combinatorial library synthesis, affording structurally and stereochemically diverse scaffolds for medicinal chemistry.


  • Open Access

    Synthesis and screening of a library of Lewisx deoxyfluoro-analogues reveals differential recognition by glycan-binding partners

    by Kristian Hollingsworth, Antonio Di Maio, Sarah-Jane Richards, Jean-Baptiste Vendeville, David E. Wheatley, Claire E. Council, Tessa Keenan, Hélène Ledru, Harriet Chidwick, Kun Huang, et al.

    Glycan-mediated interactions play a crucial role in biology and medicine, influencing signalling, immune responses, and disease pathogenesis. However, the use of glycans in biosensing and diagnostics is limited by cross-reactivity, as certain glycan motifs can be recognised by multiple biologically distinct protein receptors. To address this specificity challenge, we report the enzymatic synthesis of a 150-member library of site-specifically fluorinated Lewisx analogues (‘glycofluoroforms’) using naturally occurring enzymes and fluorinated monosaccharides. Subsequent incorporation of a subset of these glycans into nanoparticles or a microarray revealed a striking spectrum of distinct binding intensities across different proteins that recognise Lewisx. Notably, we show that for two proteins with unique binding sites for Lewisx, glycofluoroforms exhibited enhanced binding to one protein, whilst reduced binding to the other, with selectivity governed by fluorination patterns. We finally showcase the potential diagnostic utility of this approach in glycofluoroform-mediated bacterial toxin detection by lateral flow.


  • A method for the systematic selection of enzyme panel candidates by solving the maximum diversity problem

    by Christian Atallah, Katherine James, Zhen Ou, James Skelton, David Markham, Matt S. Burridge, James Finnigan, Simon Charnock, Anil Wipat


  • Automatic Diverse Subset Selection From Enzyme Families by Solving the Maximum Diversity Problem

    by Christian Atallah, Katherine James, Zhen Ou, James Skelton, David Markham, James Finnigan, Simon Charnock, Anil Wipat

    Enzymes are being increasingly exploited in various industries for their potential as biocatalysts. Increasing the portfolio of available and useful biocatalysts depends on the reliable annotation of enzyme catalytic function. However, the required quality of such annotation can only be confidently guaranteed through experimental characterisation in the laboratory. The selection of catalytically diverse enzyme panels for experimentally characterisation is therefore an important step for shedding light on the currently unannotated proteins in enzyme families. As current selection methods lack efficiency and scalability, and are non systematic, we present a novel approach for the automatic selection of subsets from enzyme families. A tabu search algorithm solving the maximum diversity problem for sequence identity was designed and implemented, and applied on three diverse enzyme families. We show that this approach automatically selects panels of enzymes that contain high richness and relative abundance of the known catalytic functions, and outperforms other methods such as k-medoids.

  • Chemoenzymatic Cascades for the Enantioselective Synthesis of β‐Hydroxysulfides Bearing a Stereocentre at the C−O or C−S Bond by Ketoreductases

    by Fei Zhao, Kate Lauder, Siyu Liu, James D. Finnigan, Simon B. R. Charnock, Daniele Castagnolo

    Chiral β‐hydroxysulfides are an important class of organic compounds which find broad application in organic and pharmaceutical chemistry. Herein we describe the development of novel biocatalytic and chemoenzymatic methods for the enantioselective synthesis of β‐hydroxysulfides by exploiting ketoreductase (KRED) enzymes. Four KREDs were discovered from a pool of 384 enzymes identified and isolated through a metagenomic approach. KRED311 and KRED349 catalysed the synthesis of β‐hydroxysulfides bearing a stereocentre at the C−O bond with opposite absolute configurations and excellent ee values by novel chemoenzymatic and biocatalytic‐chemical‐biocatalytic (bio‐chem‐bio) cascades starting from commercially available thiophenols/thiols and α‐haloketones/alcohols. KRED253 and KRED384 catalysed the enantioselective synthesis of β‐hydroxysulfides bearing a stereocentre at the C−S bond with opposite enantioselectivities by dynamic kinetic resolution (DKR) of racemic α‐thioaldehydes.


  • Chemoenzymatic Cascades for the Enantioselective Synthesis of β‐Hydroxysulfides Bearing a Stereocentre at the C−O or C−S Bond by Ketoreductases

    by Fei Zhao, Kate Lauder, Siyu Liu, James D. Finnigan, Simon B. R. Charnock, Daniele Castagnolo

    Chiral β‐hydroxysulfides are an important class of organic compounds which find broad application in organic and pharmaceutical chemistry. Herein we describe the development of novel biocatalytic and chemoenzymatic methods for the enantioselective synthesis of β‐hydroxysulfides by exploiting ketoreductase (KRED) enzymes. Four KREDs were discovered from a pool of 384 enzymes identified and isolated through a metagenomic approach. KRED311 and KRED349 catalysed the synthesis of β‐hydroxysulfides bearing a stereocentre at the C−O bond with opposite absolute configurations and excellent ee values by novel chemoenzymatic and biocatalytic‐chemical‐biocatalytic (bio‐chem‐bio) cascades starting from commercially available thiophenols/thiols and α‐haloketones/alcohols. KRED253 and KRED384 catalysed the enantioselective synthesis of β‐hydroxysulfides bearing a stereocentre at the C−S bond with opposite enantioselectivities by dynamic kinetic resolution (DKR) of racemic α‐thioaldehydes.